Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design
Condition(s):HypertensionLast Updated:March 28, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):HypertensionLast Updated:March 28, 2024Active, not recruiting
Condition(s):Systemic Arterial Hypertension; Pharmacotherapy; Pharmaceutical CareLast Updated:October 5, 2022Completed
Condition(s):Idiopathic Intracranial HypertensionLast Updated:December 12, 2018Completed
Condition(s):Hypertension; HIV-1-infectionLast Updated:July 12, 2023Recruiting
Condition(s):HypertensionLast Updated:October 4, 2021Unknown status
Condition(s):HIV/AIDS; HypertensionLast Updated:May 17, 2022Recruiting
Condition(s):HypertensionLast Updated:March 20, 2020Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 15, 2018Completed
Condition(s):Adherence to Personalized EBM Antihypertensive Drug Prescriptions for Patients With Hypertension and Comorbidities in Everyday Clinical PracticeLast Updated:March 11, 2021Unknown status
Condition(s):Medication Adherence; Mental Health Issue; Self Efficacy; Hypertension; Epilepsy; DiabetesLast Updated:December 22, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.